Skip to content
Keeping Current CME cover art

All Episodes

Keeping Current CME — 785 episodes · page 1 of 8

#
Title
1

Managing MASH in the Modern Era - Episode 5: The MASH Care Pathway—The Role of Advanced Practice Providers

2

Breaking Through Bottlenecks in Care for Pediatric Atopic Dermatitis

3

Managing MASH in the Modern Era - Episode 4: Managing MASH: What the Endocrinologist Needs to Know

4

Waking Up to OSA: Addressing Barriers to Care and Encouraging Clinical Action

5

A New Chapter in IgA Nephropathy Care: Applying Evidence-Based Practices for B-Cell–Modulating Therapies

6

The Retina Futures Forum: Focus on Diabetic Eye Disease

7

A Candid Talk on IgA Nephropathy and B Cell Misfires

8

Alzheimer's Disease Precision Diagnostics: A 3-Part Live Masterclass: Part 2 - Cerebrospinal Fluid Biomarkers

9

Managing MASH in the Modern Era – Episode 3: Metabolic Disease and MASH: What the Endocrinologist Needs to Know

10

Reading the Signal: What Repeated Oral Steroid Use Tells Us in Chronic Rhinosinusitis With Nasal Polyps

11

Keeping Current With COVID-19 Prevention: Expert Insights on Post-Exposure Prophylaxis

12

Timing Matters: Optimizing Biologic Escalation in Moderate to Severe Asthma

13

Current Concepts in the Treatment of MASH

14

The Phosphate Binder Pivot: Navigating Patient Conversations for Novel Hyperphosphatemia Interventions

15

When Steroids Signal Risk: Rethinking COPD Exacerbation Management

16

The Nurse Practitioner as the Medical Home for the Patient With Rett Syndrome

17

Right Care, Right Time: Clinical Pathways for Identifying and Referring Moderate to Severe Asthma

18

Inside the Edit: Lessons From the Field and Emerging Implications for HAE

19

The Chronic Kidney Disease Checkpoint: Keeping Current in Anemia Care for Dialysis-Dependent Patients

20

The Retina Futures Forum: Focus on RVO

21

Interrupting the Pattern: Reducing Steroid Dependence in Moderate to Severe Asthma Through Biologic-Driven Care

22

Breaking Boundaries: Exploring the Latest Advances in Lupus

23

Dravet Syndrome: Where Do Current Therapies Miss the Mark?

24

The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps

25

The Intensity Equation: Aligning Multiple Myeloma Combination Strategies With Current Evidence

26

Beyond the Flare: Rethinking Steroid Use and Disease Trajectory in Pediatric Asthma

27

Elevating CLL Care: Integrating Evidence, Guidelines, and the Patient Perspective

28

Optimizing Breast MRI Surveillance in High-Risk Patients: Strategies for Repeat Imaging Excellence

29

Translating Emerging Evidence in IgA Nephropathy: Proteinuria and eGFR as Biomarkers of Disease Progression

30

Alzheimer's Disease Precision Diagnostics: A 3-Part Live Master Class. Part 1: Amyloid Positron Emission Tomography

31

The Triple Monoamine Interplay: What's New in ADHD Treatment

32

Redefining the Patient Journey: The Promise and Practice in NTRK Fusion–Positive Cancers

33

Advancing Corticosteroid Stewardship Across Airway Diseases: When Steroids Signal Risk

34

Protecting the Heart and Kidneys: Primary Care Strategies for Improving Cardio-Kidney-Metabolic Health

35

Helping Patients Implement a Plan for Nicotine Cessation

36

Diagnosing and Managing Obesity-Linked Liver Disease: A Multidisciplinary Masterclass

37

Ask the Experts: Best Practices in Using AID to Simplify Life or Reduce Burden in People Living With T2D

38

Front Line in T2D: Advancing Care With Basal Insulin Excellence

39

Evidence-Based Initiatives for Nicotine Use Prevention

40

Updates on Anti-Seizure Medications for the Management of Lennox-Gastaut Syndrome

41

Pharmacological and Combination Interventions for Nicotine Cessation

42

Next-Generation Gadolinium-Based Contrast Agents: Advancing MRI

43

New Frontiers in IgA Nephropathy: Understanding the Role of B-Cell Modulation

44

Case-Based Discussion on Linking Cognitive Testing With Biomarker Testing in Alzheimer's Disease

45

The Retina Futures Forum: Focus on Wet AMD

46

The New Era of mHSPC Treatment: Evaluating Emerging Doublet and Triplet Combinations

47

The Health Risks of Nicotine Use: A Focus on At-Risk Populations

48

Best Practices in Clinician-Patient Shared Decision-Making for Depression Treatment

49

CETP Inhibition: What We've Learned and What's Next: Quickfire Countdown

50

In the Clinic: Managing Emotional Dysregulation and Executive Dysfunction in an Adult With ADHD

51

From Data to the Dialysis Unit: Integrating Novel Therapies for Hyperphosphatemia in Dialysis-Dependent CKD

52

Hot Off the Press: New Evidence for Emerging Therapies in Nondiabetic CKD Management

53

Ask the Experts: Best Practices in Using AID to Solve Titration Challenges in People Living With T2D

54

Marketing Influence Related to Nicotine-Containing Products

55

Behavioral and Non-Pharmacologic Interventions for Nicotine Cessation

56

Updates on Metabolic Dysfunction-Associated Steatohepatitis Treatment

57

Unlocking the Enigma of Low Back Pain: Zeroing In on Effective Treatment Options

58

Managing MASH in the Modern Era - Episode 2: Managing MASH: A Guide for GI Specialists

59

Chronic Lymphocytic Leukemia: Data-Driven Updates in First-Line and R/R Disease

60

Personalizing Cardiovascular Prevention: From Methods to Meaning

61

Navigating Next Steps in CLL: A Collaborative Dialogue

62

Navigating the Psychosocial Impact of Dermatologic Disease: The Patient Journey

63

Advancing Care in Acromegaly: Expert Insights on Optimizing Current Diagnostic and Care Strategies

64

The Patient Voice in MDD: Why and When to Augment Therapy

65

Managing Erosive Esophagitis: When PPIs Are Insufficient

66

CKD and the Heart: An Expert Digest From WCN 2026

67

Advocating for Nicotine-Free Youth and a Healthy Community

68

Breaking News in IBS-C: Real-World Expert Insights, Patient Voices, and Challenging Cases

69

Ready for Launch in Gastroesophageal Adenocarcinoma: Anti-HER2 Innovation in First-Line Management

70

Orexin and Hyperarousal in MDD: A Rapid-Fire Review

71

Beyond Sedation: Reexamining Insomnia as a Core Symptom of MDD: The Role of Novel Orexin-Based Strategies

72

Beyond the Total Score: Screening and Diagnosing the Challenging Symptoms of Depression

73

Expert Panel Decision Framework: Progressive Strategies for Managing HER2-Mutated Advanced NSCLC

74

Imaging in Action: Patient Cases

75

Rett Syndrome Year In Review: What We Learned in 2025 and Beyond

76

Managing MASH in the Modern Era - Episode 1: Identifying MASH for GI Specialists

77

Interprofessional Approach to Adverse Event Care for the Patient With High-Risk Hormone Receptor-Positive/HER2-Negative Early Breast Cancer

78

Addressing the Intersection Between Heart Failure and Kidney Disease: Have We Reached a Consensus?

79

Connect With Your Patient Living With Depression: Are They a Good Candidate for an Augmentation Treatment?

80

Beyond Lifestyle: Managing Cardiovascular Risk With Medications

81

Sharing the Decision of Treatment Planning in High-Risk HR+/HER2- Early Breast Cancer

82

Personalizing Risk Assessment to Enhance Cardiovascular Prevention: Quickfire Countdown With Imaging Experts

83

Noninvasive Assessment of MASH Fibrosis

84

Rapid Fire: Your Questions on Obesity and Liver Disease Answered

85

Best Practices in Patient Communication When Introducing Biosimilars Into Multiple Sclerosis Care

86

Ask the Experts: Best Practices in Using AID to Achieve Outcomes Faster and Safely in People Living With T2D

87

Carotid Ultrasound: Seeing Vascular Age

88

The Practical Community Colorectal Cancer Clinic: Aligning Biomarker Analysis to Treatment Selection

89

Empowering Frontline Care in IBS-C: Moving Beyond OTC Therapies

90

The Right Fit: Personalizing COPD Device Selection Across the Patient Journey

91

When Monotherapy Fails in Depression: An Evidence-Based Update

92

From Symptoms to Success: Real-World Cases in Patient-Centered IBS-C Care

93

Multidisciplinary Management of Metabolic Dysfunction-Associated Steatohepatitis

94

Advancing Care in HER2-Mutated NSCLC: Evidence, Diagnostics, and Future Directions

95

The Mechanisms Behind Rapid-Acting Treatments for Major Depressive Disorder

96

Cracking the Code With Coronary Artery Calcium (CAC)

97

Cracking the Code: Optimizing Outcomes in All Patients With High-Risk HR+/HER2-Negative Early Breast Cancer

98

Breaking the OTC Cycle: Optimizing Prescription Therapy for IBS-C in Everyday Practice

99

Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer

100

Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence